Ignite Creation Date:
2024-05-06 @ 12:40 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01636947
Status:
COMPLETED
Last Update Posted:
2018-09-25
First Post:
2012-07-05
Brief Title:
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy Non-doxorubicin Hydrochloride Adriamycin and Cyclophosphamide Regimens MK-0869-225 KMEC
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC